In the BioHarmony Drug Report Database

"Preview" Icon

Atomoxetine

Strattera (atomoxetine) is a small molecule pharmaceutical. Atomoxetine was first approved as Strattera on 2002-11-26. It is used to treat attention deficit disorder with hyperactivity in the USA. The pharmaceutical is active against sodium-dependent noradrenaline transporter. In addition, it is known to target sodium-dependent dopamine transporter and sodium-dependent serotonin transporter.

 

Trade Name

 

Strattera
 

Common Name

 

atomoxetine
 

ChEMBL ID

 

CHEMBL641
 

Indication

 

attention deficit disorder with hyperactivity
 

Drug Class

 

Antidepressants (fluoxetine type)

Image (chem structure or protein)

Atomoxetine structure rendering